🚀 VC round data is live in beta, check it out!
Abbott Pakistan Valuation Multiples
Discover revenue and EBITDA valuation multiples for Abbott Pakistan and similar public comparables like TaiDoc Technology, ClearPoint Neuro, CellaVision, Asterasys and more.
Abbott Pakistan Overview
About Abbott Pakistan
Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.
Founded
1948
HQ
Employees
1.4K
Website
Sectors
Financials (FY)
EV
$346M
Abbott Pakistan Financials
Abbott Pakistan reported last fiscal year revenue of $245M and EBITDA of $39M.
In the same fiscal year, Abbott Pakistan generated $71M in gross profit, $39M in EBITDA, and $19M in net income.
Revenue (LTM)
Abbott Pakistan P&L
In the most recent fiscal year, Abbott Pakistan reported revenue of $245M and EBITDA of $39M.
Abbott Pakistan expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $245M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $71M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 29% | XXX | XXX | XXX |
| EBITDA | — | XXX | $39M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 16% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 13% | XXX | XXX | XXX |
| Net Profit | — | XXX | $19M | XXX | XXX | XXX |
| Net Margin | — | XXX | 8% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Abbott Pakistan Stock Performance
Abbott Pakistan has current market cap of $377M, and enterprise value of $346M.
Market Cap Evolution
Abbott Pakistan's stock price is $3.85.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $346M | $377M | 0.4% | XXX | XXX | XXX | $0.19 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAbbott Pakistan Valuation Multiples
Abbott Pakistan trades at 1.4x EV/Revenue multiple, and 8.8x EV/EBITDA.
EV / Revenue (LTM)
Abbott Pakistan Financial Valuation Multiples
As of March 7, 2026, Abbott Pakistan has market cap of $377M and EV of $346M.
Equity research analysts estimate Abbott Pakistan's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Abbott Pakistan has a P/E ratio of 20.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $377M | XXX | $377M | XXX | XXX | XXX |
| EV (current) | $346M | XXX | $346M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 8.8x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 11.3x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 4.9x | XXX | XXX | XXX |
| P/E | — | XXX | 20.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 58.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Abbott Pakistan Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Abbott Pakistan Margins & Growth Rates
Abbott Pakistan's revenue in the last fiscal year grew by 23%.
Abbott Pakistan Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 23% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 160% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 8% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 17% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Abbott Pakistan Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| TaiDoc Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| ClearPoint Neuro | XXX | XXX | XXX | XXX | XXX | XXX |
| CellaVision | XXX | XXX | XXX | XXX | XXX | XXX |
| Asterasys | XXX | XXX | XXX | XXX | XXX | XXX |
| Standard BioTools | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Abbott Pakistan M&A Activity
Abbott Pakistan acquired XXX companies to date.
Last acquisition by Abbott Pakistan was on XXXXXXXX, XXXXX. Abbott Pakistan acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Abbott Pakistan
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAbbott Pakistan Investment Activity
Abbott Pakistan invested in XXX companies to date.
Abbott Pakistan made its latest investment on XXXXXXXX, XXXXX. Abbott Pakistan invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Abbott Pakistan
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Abbott Pakistan
| When was Abbott Pakistan founded? | Abbott Pakistan was founded in 1948. |
| Where is Abbott Pakistan headquartered? | Abbott Pakistan is headquartered in Pakistan. |
| How many employees does Abbott Pakistan have? | As of today, Abbott Pakistan has over 1K employees. |
| Is Abbott Pakistan publicly listed? | Yes, Abbott Pakistan is a public company listed on Pakistan Stock Exchange. |
| What is the stock symbol of Abbott Pakistan? | Abbott Pakistan trades under ABOT ticker. |
| When did Abbott Pakistan go public? | Abbott Pakistan went public in 1982. |
| Who are competitors of Abbott Pakistan? | Abbott Pakistan main competitors are TaiDoc Technology, ClearPoint Neuro, CellaVision, Asterasys. |
| What is the current market cap of Abbott Pakistan? | Abbott Pakistan's current market cap is $377M. |
| What is the current revenue of Abbott Pakistan? | Abbott Pakistan's last fiscal year revenue is $245M. |
| What is the current EV/Revenue multiple of Abbott Pakistan? | Current revenue multiple of Abbott Pakistan is 1.4x. |
| Is Abbott Pakistan profitable? | No, Abbott Pakistan is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.